Corponi F.; Fabbri C.; Bitter I.; Montgomery S.; Vieta E.; Kasper S.; Pallanti S.; Serretti A., Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone, «EUROPEAN NEUROPSYCHOPHARMACOLOGY», 2019, 29, pp. 971 - 985 [articolo]Open Access
Corponi F.; Fabbri C.; Serretti A., Pharmacogenetics and depression: A critical perspective, «PSYCHIATRY INVESTIGATION», 2019, 16, pp. 645 - 653 [articolo]
Fanelli G.; Benedetti F.; Wang S.-M.; Lee S.-J.; Jun T.-Y.; Masand P.S.; Patkar A.A.; Han C.; Serretti A.; Pae C.-U.; Fabbri C., Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression, «JOURNAL OF AFFECTIVE DISORDERS», 2019, 249, pp. 410 - 417 [articolo]
Bartova L.; Dold M.; Kautzky A.; Fabbri C.; Spies M.; Serretti A.; Souery D.; Mendlewicz J.; Zohar J.; Montgomery S.; Schosser A.; Kasper S., Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice, «THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY», 2019, 20, pp. 427 - 448 [articolo]
Fabbri C.; Corponi F.; Souery D.; Kasper S.; Montgomery S.; Zohar J.; Rujescu D.; Mendlewicz J.; Serretti A., The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives, «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2019, 22, pp. 93 - 104 [articolo]Open Access
Valli I.; Fabbri C.; Young A.H., Uncovering neurodevelopmental features in bipolar affective disorder, «BRITISH JOURNAL OF PSYCHIATRY», 2019, 215, pp. 383 - 385 [articolo]
Fabbri C.; Tansey K.E.; Perlis R.H.; Hauser J.; Henigsberg N.; Maier W.; Mors O.; Placentino A.; Rietschel M.; Souery D.; Breen G.; Curtis C.; Lee S.-H.; Newhouse S.; Patel H.; O'Donovan M.; Lewis G.; Jenkins G.; Weinshilboum R.M.; Farmer A.; Aitchison K.J.; Craig I.; McGuffin P.; Schruers K.; Biernacka J.M.; Uher R.; Lewis C.M., Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies, «EUROPEAN NEUROPSYCHOPHARMACOLOGY», 2018, 28, pp. 945 - 954 [articolo]
Ren H.; Fabbri C.; Uher R.; Rietschel M.; Mors O.; Henigsberg N.; Hauser J.; Zobel A.; Maier W.; Dernovsek M.Z.; Souery D.; Cattaneo A.; Breen G.; Craig I.W.; Farmer A.E.; McGuffin P.; Lewis C.M.; Aitchison K.J., Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP), «TRANSLATIONAL PSYCHIATRY», 2018, 8, Article number: 150, pp. 150 - 160 [articolo]Open Access
Zwicker A.; Fabbri C.; Rietschel M.; Hauser J.; Mors O.; Maier W.; Zobel A.; Farmer A.; Aitchison K.J.; McGuffin P.; Lewis C.M.; Uher R., Genetic disposition to inflammation and response to antidepressants in major depressive disorder, «JOURNAL OF PSYCHIATRIC RESEARCH», 2018, 105, pp. 17 - 22 [articolo]
Caraci F.; Calabrese F.; Molteni R.; Bartova L.; Dold M.; Leggio G.M.; Fabbri C.; Mendlewicz J.; Racagni G.; Kasper S.; Riva M.A.; Drago F., International union of basic and clinical pharmacology CIV: The neurobiology of treatment-resistant depression: From antidepressant classifications to novel pharmacological targets, «PHARMACOLOGICAL REVIEWS», 2018, 70, pp. 475 - 504 [articolo]
Fabbri C.; Tansey K.E.; Perlis R.H.; Hauser J.; Henigsberg N.; Maier W.; Mors O.; Placentino A.; Rietschel M.; Souery D.; Breen G.; Curtis C.; Sang-Hyuk L.; Newhouse S.; Patel H.; Guipponi M.; Perroud N.; Bondolfi G.; O'Donovan M.; Lewis G.; Biernacka J.M.; Weinshilboum R.M.; Farmer A.; Aitchison K.J.; Craig I.; McGuffin P.; Uher R.; Lewis C.M., New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR∗D studies: Rare variant analysis and high-density imputation, «PHARMACOGENOMICS JOURNAL», 2018, 18, pp. 413 - 421 [articolo]
Fabbri C.; Lewis C.M.; Perlis R.H.; Uher R., No association between antidepressant efficacy and rs28365143 in corticotropin-releasing hormone binding protein in a large meta-analysis, «THE AMERICAN JOURNAL OF PSYCHIATRY», 2018, 175, pp. 575 - 576 [replica/breve intervento]
Fabbri, Chiara; Zohar, Joseph; Serretti, Alessandro*, Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials, «PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY», 2018, 86, pp. 36 - 44 [articolo]
Corponi, Filippo; Fabbri, Chiara; Serretti, Alessandro*, Pharmacogenetics in Psychiatry, in: Pharmacogenetics, San Diego, Elsevier Science, 2018, pp. 297 - 331 (ADVANCES IN PHARMACOLOGY) [capitolo di libro]
Fabbri, Chiara; Corponi, Filippo; Albani, Diego; Raimondi, Ilaria; Forloni, Gianluigi; Schruers, Koen; Kasper, Siegfried; Kautzky, Alexander; Zohar, Joseph; Souery, Daniel; Montgomery, Stuart; Cristalli, Carlotta Pia; Mantovani, Vilma; Mendlewicz, Julien; Serretti, Alessandro*, Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance, «PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY», 2018, 81, pp. 203 - 210 [articolo]
